NASDAQ:CRON - Cronos Group Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $8.19
  • Forecasted Upside: -3.34 %
  • Number of Analysts: 8
  • Breakdown:
  • 2 Sell Ratings
  • 4 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$8.47
▲ +0.5 (6.27%)
1 month | 3 months | 12 months
Get New Cronos Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CRON and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CRON

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$8.19
▼ -3.34% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Cronos Group in the last 3 months. The average price target is $8.19, with a high forecast of $11.00 and a low forecast of $5.00. The average price target represents a -3.34% upside from the last price of $8.47.
Hold
The current consensus among 8 investment analysts is to hold stock in Cronos Group. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 2 sell ratings
6/8/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 2 sell ratings
9/6/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 8 hold ratings
  • 2 sell ratings
12/5/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 1 sell ratings
3/4/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 1 sell ratings
6/2/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 1 sell ratings
8/31/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 1 sell ratings
10/30/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 2 sell ratings
11/29/2020

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 2 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/17/2020Raymond JamesBoost Price TargetOutperform$10.00 ➝ $11.00Low
i
Rating by Rahul Sarugaser at Raymond James
11/16/2020Jefferies Financial GroupLower Price TargetUnderperform$5.60 ➝ $5.00Low
i
11/6/2020Raymond JamesSet Price TargetOutperform$10.00High
i
Rating by Rahul Sarugaser at Raymond James
9/14/2020Raymond JamesSet Price TargetOutperform$10.00High
i
Rating by Rahul Sarugaser at Raymond James
9/8/2020Raymond JamesSet Price TargetOutperform$10.00Medium
i
Rating by Rahul Sarugaser at Raymond James
9/2/2020Raymond JamesSet Price TargetOutperform$10.00High
i
Rating by Rahul Sarugaser at Raymond James
8/18/2020Raymond JamesSet Price TargetOutperform$10.00Low
i
Rating by Rahul Sarugaser at Raymond James
8/7/2020Raymond JamesSet Price TargetOutperform$10.00N/A
i
Rating by Rahul Sarugaser at Raymond James
6/23/2020Raymond JamesUpgradeMarket Perform ➝ Outperform$6.50 ➝ $13.52High
i
5/22/2020Raymond JamesSet Price TargetMarket Perform$6.50Medium
i
5/11/2020Pi FinancialReiterated RatingHold$8.50Medium
i
5/11/2020Raymond JamesSet Price TargetMarket Perform$6.50Low
i
5/11/2020Canaccord GenuityReiterated RatingSell$6.50High
i
5/11/2020Stifel NicolausLower Price TargetHold$8.00 ➝ $7.50High
i
4/27/2020Raymond JamesDowngradeOutperform ➝ Market Perform$10.50 ➝ $6.50High
i
4/19/2020Piper SandlerDowngradeOverweight ➝ NeutralMedium
i
Rating by Michael Lavery at Piper Sandler
4/13/2020Piper SandlerDowngradeOverweight ➝ Neutral$12.00 ➝ $7.00High
i
Rating by Michael Lavery at Piper Sandler
4/2/2020Bank of AmericaDowngradeBuy ➝ Neutral$9.00Low
i
3/31/2020Canaccord GenuityDowngradeHold ➝ SellHigh
i
3/4/2020MKM PartnersUpgradeNeutral ➝ Buy$12.00 ➝ $11.00High
i
3/3/2020Stifel NicolausDowngradeBuy ➝ Hold$12.00 ➝ $8.00High
i
Rating by W. Andrew Carter at Stifel Nicolaus
12/21/2019Raymond JamesSet Price TargetOutperform$12.00Low
i
11/13/2019CIBCReiterated RatingBuy$17.00High
i
10/22/2019Piper Jaffray CompaniesLower Price TargetOverweight$18.00 ➝ $12.00Low
i
Rating by Michael Lavery at Piper Jaffray Companies
10/18/2019Stifel NicolausUpgradeHold ➝ Buy$16.50 ➝ $14.00High
i
9/19/2019MKM PartnersInitiated CoverageNeutral$14.00Low
i
9/5/2019BMO Capital MarketsUpgradeUnderperform ➝ Market PerformHigh
i
Rating by Tamy Chen at BMO Capital Markets
8/12/2019Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$18.00Medium
i
8/9/2019BMO Capital MarketsReiterated RatingSellMedium
i
Rating by Tamy Chen at BMO Capital Markets
8/9/2019Bank of AmericaBoost Price TargetBuy$20.00 ➝ $26.00Low
i
Rating by Christopher Carey at Bank of America Co.
8/9/2019Canaccord GenuityUpgradeSell ➝ Hold$16.00 ➝ $17.00High
i
6/28/2019Consumer EdgeInitiated CoverageEqual Weight ➝ Equal WeightLow
i
6/5/2019Stifel NicolausInitiated CoverageHold ➝ HoldLow
i
6/5/2019Bank of AmericaUpgradeUnderperform ➝ Buy$13.00 ➝ $20.00High
i
Rating by Christopher Carey at Bank of America Co.
4/17/2019Bank of AmericaInitiated CoverageUnderperform ➝ Underperform$13.00Medium
i
3/27/2019CIBCSet Price TargetBuy$30.00Low
i
Rating by John Zamparo at CIBC
3/27/2019Canaccord GenuityDowngradeHold ➝ Sell$17.00High
i
3/26/2019Pi FinancialReiterated RatingBuy ➝ Neutral$24.00High
i
3/11/2019BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$21.43Low
i
3/7/2019Eight CapitalDowngradeHoldLow
i
Rating by Graeme Kreindler at Eight Capital
3/5/2019CowenInitiated CoverageMarket PerformHigh
i
2/25/2019Jefferies Financial GroupInitiated CoverageUnderperform ➝ UnderperformHigh
i
2/5/2019GMP SecuritiesDowngradeBuy ➝ HoldHigh
i
1/18/2019CIBCInitiated CoverageSector Outperform ➝ Sector OutperformHigh
i
11/19/2018GMP SecuritiesReiterated RatingBuyMedium
i
11/15/2018Canaccord GenuityReiterated RatingHold ➝ Average$9.00Low
i
8/15/2018Canaccord GenuityUpgradeSell ➝ HoldHigh
i
5/4/2018Beacon SecuritiesReiterated RatingBuyLow
i
Rating by V. Ajamain at Beacon Securities
5/1/2018Canaccord GenuityDowngradeHold ➝ SellHigh
i
4/6/2018GMP SecuritiesUpgradeHold ➝ BuyHigh
i
(Data available from 11/29/2015 forward)
Cronos Group logo
Cronos Group Inc. operates as a cannabinoid company in the United States and internationally. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through ecommerce, retail, and hospitality partner channels. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. Its brand portfolio includes PEACE NATURALS, a global wellness platform; adult-use brands comprise COVE and Spinach; and hemp-derived CBD brands consists of Lord Jones and PEACE+. Cronos Group Inc. is based in Toronto, Canada.
Read More

Today's Range

Now: $8.47
$7.63
$8.56

50 Day Range

MA: $6.39
$5.29
$8.02

52 Week Range

Now: $8.47
$4.00
$9.00

Volume

7,217,476 shs

Average Volume

8,676,208 shs

Market Capitalization

$3.02 billion

P/E Ratio

35.29

Dividend Yield

N/A

Beta

1.65